Dendrimer-Coated Carbohydrate Residues as Drug Delivery Trojan Horses in Glycoscience

Dendrimer-Based Drug Delivery Systems: From Theory to Practice

Volumn , Issue , 2012, Pages 407-438

  Chabre, Yoann M ^a   Roy, René ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

"artificial glycoforms," in multivalent carbohydrate protein interactions; Dendrimer coated carbohydrate residues, as drug delivery Trojan horses; Galactosides, glycodendrimers in targeting bacterial, viral and specific tissues; Glycodendrimers as targeting warheads, counteracting adhesion of pathogens; Multivalent carbosilane scaffolds, "SUPER TWIGs," therapeutic for Shiga toxin

Indexed keywords

EID: 84884790598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118275238.ch11     Document Type: Chapter

References (101)

1. Chabre, Y.M., Roy, R. (2010). Design and creativity in synthesis of multivalent neoglycoconjugates. Adv. Carbohydr. Chem. Biochem., 63, 165-393;
2. Chabre, Y. M., Roy, R. (2009). The Chemist's way to prepare multivalency. In The Sugar Code. Fundamentals of Glycosciences;Gabius, H.-J. Ed., Wiley-VCH Verlag GmbH & Co, Weinheim, pp. 53-70;
3. Chabre, Y.M., Roy, R. (2008). Recent trends in glycodendrimer syntheses and applications. Curr. Top. Med. Chem., 8, 1237-1285
4. Roy, R. (2003). A decade of glycodendrimer chemistry. Trends Glycosci. Glycotechnol., 15, 291-310.
5. Deniaud, D., Julienne, K., Gouin, S.G. (2011). Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands. Org. Biomol. Chem., 9, 966-979;
6. Lahmann, M. (2009). Architectures of multivalent glycomimetics for probing carbohydrate-lectin interactions. Top. Curr. Chem., 288, 17-65.
7. Davis, B.G. (2002). Synthesis of glycoproteins. Chem. Rev., 102, 579-601.
8. Herzner, H., Reipen, T., Schultz, M., Kunz, H. (2000) Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs. Chem. Rev., 100, 4495-4537.
9. Sihorkar, V., Vias, S.P. (2001). Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J. Pharm. Pharmaceut. Sci., 4, 138-158.
10. Roy, R. (1996). Design and synthesis of glycoconjugates. In Modern Methods in Carbohydrate Synthesis; Khan, S. H., O'Neil, A.Eds, Harwood Academic, Amsterdam, pp. 378-402.
11. Bovin, N.V., Gabius, H.-J. (2007). Polymer immobilized carbohydrate ligands versatile chemical tools for biochemistry and medical science. Chem. Soc. Rev., 45, 2059-2072.
12. de la Fuente, J.M., Barrientos, A.G., Rojas, T.C., Rojo, J., Cañada, J., Fern=andez, A., Penades, S. (2001). Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions. Angew. Chem. Int. Ed., 41, 1554-1557.
13. Perez-Balderas, F., Morales-Sanfrutos, J., Hernàndez-Mateo, F., Isac-Garcìa, J., Santoyo-Gonzàlez, F. (2009). Click multivalent homogeneous neoglycoconjugates- Synthesis and evaluation of their binding affinities. Eur. J. Org. Chem., 2441-2453;
14. Ortega-Muñoz, M., Perez-Balderas, F., Morales-Sanfrutos, J., Hernàndez-Mateo, F., Isac-Garcìa, J., Santoyo-Gonzàlez, F. (2009). Click multivalent heterogeneous neoglycoconjugates-Modular synthesis and evaluation of their binding affinities. Eur. J. Org. Chem. 2454-2473.
15. Röglin, L., Lempens, E.H.M., Meijer, E.W. (2011). A synthetic "Tour de Force":Welldefined multivalent and multimodal dendritic structures for biomedical applications. Angew. Chem. Int. Ed., 50, 102-112;
16. Rosen, B.M., Wilson, C.J., Wilson, D.A., Peterca, M., Imam, M.R., Percec, V. (2009). Dendron-mediated self-assembly, disassembly, and self-organization of complex systems. Chem. Rev., 109, 6275-6540;
17. Li, Y., Cheng, Y., Xu, T. (2007). Design, synthesis and potent pharmaceutical applications of glycodendrimers: A mini review. Curr. Drug Discovery Technol., 4, 246-254;
18. Nepogodiev, S.A., Stoddart, J.F. (2003). Glycodendrimers: chemical aspects. Adv. Macromol. Carbohydr. Res., 2, 191-239;
19. Cloninger, M.J. (2002). Biological applications of dendrimers. Curr. Opin. Chem. Biol., 6, 742-748;
20. Bezouska, K. (2002). Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). Rev. Molec. Biotechnol., 90, 269-290;
21. Turnbull W.B., Stoddart, J.F. (2002). Design and Synthesis of Glycodendrimers. Rev. Molec. Biotechnol., 90, 231-255;
22. Röckendorf N., Lindhorst, T. K. (2001). Glycodendrimers. Top. Curr. Chem., 217, 201-238.
23. Roy, R. (1996). Syntheses and some applications of chemically defined multivalent glycoconjugates. Curr. Opin. Struct. Biol., 6, 692-702
24. Mann, D.A., Kanai, M., Maly, D.J., Kiessling, L.L. (1998). Probing low affinity and multivalent interactions with surface plasmon resonance: ligands for concanavalin A. J. Am. Chem. Soc., 120, 10575-10582.
25. Dam, T.K., Roy, R., Pagé, D., Brewer, C.F. (2002). Thermodynamic binding parameters of individual epitopes of multivalent carbohydrates to concanavalin A as determined by "reverse" isothermal titration microcalorimetry. Biochemistry, 41, 1359-1363.
26. Lundquist, J.L., Toone, E.J. (2002). The cluster glycoside effect. Chem. Rev., 102, 555-578;
27. Kiessling, L.L., Getswicki, J.E., Strong, L.E. (2006). Synthetic multivalent ligands as probes of signal transduction. Angew. Chem. Int. Ed., 45, 2348-2368.
28. Dwek, R.A. (1996). Glycobiology: toward understanding the function of sugars. Chem. Rev., 96, 683-720.
29. Bertozzi, C.R., Kiessling, L.L. (2001). Chemical glycobiology. Science, 291, 2357-2364.
30. Choi, S.K. (2004). In Synthetic Multivalent Molecules: Concepts and Biomedical Applications,Wiley, New York;
31. Mammen, M., Choi, S.-K., Whitesides, G.M. (1998). Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed., 37, 2754-2794.
32. Varki, A. (1997). Biological roles of oligosaccharides: all of the theories are correct. Glycobiology, 3, 97-130.
33. Dwek, R.A. (1998). Biological importance of glycosylation. Dev. Biol. Stand., 96, 43-47.
34. Lee, Y.C., Lee, R.T. (1995). Carbohydrate-protein interactions: basis of glycobiology. Acc. Chem. Res., 28, 321-327.
35. Kiessling, L.L., Gestwicki, J.E., Strong, L.E. (2000). Synthetic multivalent ligands in the exploration of cell surface interactions. Curr. Opin. Chem. Biol., 4, 696-703;
36. Kiessling, L.L., Strong, L.E., Gestwicki, J.E. (2000). Principles for multivalent ligand design. Annu. Rep. Med. Chem., 35, 321-330.
37. Imberty, A., Chabre, Y.M., Roy, R. (2008). Glycomimetics and glycodendrimers as high affinity microbial antiadhesins. Chem. Eur. J., 14, 7490-7499.
38. Roy, R. (2000). Carbohydrate-based vaccines. In R. Roy, (Ed.), ACS Symp. Ser., 989;
39. Křenek, K., Kuldovà, M., Hulìkovà, K., Stibor, I., Lhotàk, P., Dudič, M., Budka, J., Pelantovà, H., Bezouška, K., Fišerovà, A., Křen, V. (2007). N-Acetyl-D-glucosamine substituted calix[4]arenes as stimulators ofNKcell-mediated antitumor immune response. Carbohydr. Res., 342, 1781-1792;
40. 3CS immunoadjuvant: Synthesis, characterization, and anticancer immunological evaluation. Bioconjugate Chem., 19, 751-758;
41. Krauss, I. J., Joyce, J.G., Finnefrock, A.C., Song, H.C., Dudkin, V.Y., Geng, X., Warren, J.D., Chastain, M., Shiver, J.W., Danishefsky, S.J. (2007). Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody. J. Am. Chem. Soc., 129, 11042-11044;
42. Wang, J., Li, H., Zou, G., Wang, L.-X. (2007). Novel templateassembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G Design, synthesis, and antibody binding study. Org. Biomol. Chem., 5, 1529-1540;
43. Slovin, S.F., Keding, S.J., Ragupathi, G. (2005). Immunol. Cell Biol., 83, 418-428
44. Roy, R. (2004). New trends in carbohydrate-based vaccines, Drug Discovery Today, 1, 327-336;
45. Sirois, S., Touaibia, M., Chou, K.-C., Roy, R. (2007). Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine. Curr. Med. Chem., 30, 3232-3242;
46. Verez-Bencomo, V., Fernàndez-Santana, V., Hardy, E., Toledo, M.E., Rodriguez, M.C., Heynngnezz, L., Rodriguez, A., Baly, A., Herrera, L., Izquierdo, M., Villar, A., Valdés, Y., Cosme, K., Deler, M. L., Montane, M., Garcia, E., Ramos, A., Aguilar, A., Medina, E., Toraňo, G., Sosa, I., Hernandez, I., Martǐnez, R., Muzachio, A., Carmenates, A., Costa, L., Cardoso, F., Campa, C., Diaz, M., Roy, R. (2004). A Synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science, 35, 522-525.
47. Vargas-Berenguel,A., Ortega-Caballero, F., Casas-Solvas, J.M. (2007). Supramolecular chemistry clusters with cores having guest binding abilities. Mini-Rev. Org. Chem., 47, 1-14
48. Dhanikula, R.S., Argaw, A., Bouchard, J.-F., Hildgen, P. (2008). Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Mol. Pharmaceutics, 5, 105-116;
49. Bernades, G.J. L., Kikkeri, R., Maglinao, M., Laurino, P., Collot, M., Hong, S.Y., Lepenies, B., Seeberger, P.H. (2010). Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting. Org. Biomol. Chem., 8, 4987-4996;
50. Benito, J.M., Gomez-Garcia, M., Mellet, C.O., Baussane, I., Defaye, J., Garcia Fernandez, J.M. (2004). Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimercyclodextrin conjugates. J. Am. Chem. Soc., 126, 10355-10363;
51. Wada, K., Arima, H., Tsutsumi, T., Chihara, Y., Hattori, K., Hirayama, F., Uekama, K. (2005). Improvement of gene delivery mediated by mannosylated dendrimer/a-cyclodextrin conjugates. J. Controlled Release, 104, 397-413;
52. Arima, H., Chihara,Y.,Arizono, M.,Yamashita, S., Wada, K., Hirayama, F., Uekama, K. (2006). Enhancement of gene transfer activity mediated by mannosylated dendrimer/a-cyclodextrin conjugate (generation 3, G3). J. Controlled Release, 116, 64-74.
53. Hung, C.-S., Bouckaert, J., Hung, D., Pinkner, J.,Widberg, C., De Fusco, A., Auguste, C. G., Strouse, R., Langerman, S., Waksman, G., Hultgren, S.J. (2002). Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol. Microbiol., 44, 903-915.
54. Bouckaert, J., Berglund, J., Schembri, M., De Genst, E., Cools, L.,Wuhrer, M., Hung, C.S., Pinkner, J., Slattegard, R., Zavialov, A., Choudhary, D., Langerman, S., Hultgren, S.J., Wyns, L., Klemm, P., Oscarson, S., Knight, S.D., De Greve, H. (2005). Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol. Microbiol., 55, 441-455.
55. Sharon, N. (1987). Bacterial lectins, cell-cell recognition and infectious disease. FEBS Lett., 217, 145-157.
56. Arya, P., Kutterer, K.M.K., Qin, H., Roby, J., Barnes, M.L., Kim, J.M., Roy, R. (1998). Diversity of C-linked neoglycopeptides for the exploration of subsite-assisted carbohydrate binding interactions. Bioorg. Med. Chem. Lett., 8, 1127-1132.
57. Nagahori, N., Lee, R.T., Nishimura, S.-I., Pagé, D., Roy, R., Lee,Y.C. (2002). Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands. ChemBioChem, 3, 836-844.
58. Heidecke C.D., Lindhorst, T.K. (2007). Iterative synthesis of spacered glycodendrons as oligomannoside mimetics and evaluation of their antiadhesive properties. Chem. Eur. J., 13, 9056-9067.
59. Hatch, D.M., Weiss, A.A., Kale, R.R., Iyer, S.S. (2008). Biotinylated bi-and tetraantennary glycoconjugates for Escherichia coli detection. ChemBioChem, 9, 2433-2442.
60. Touaibia, M., Shiao, T.C., Papadopoulos, A., Vaucher, J., Wang, Q., Benhamioud, K., Roy, R. (2007). Tri-and hexavalent mannoside clusters as potential inhibitors of type 1 fimbriated bacteria using pentaerythritol and triazole linkages. Chem. Commun., 380-382.
61. Meldal, M., Tornøe,W. (2008). Cu-catalyzed azide-alkyne cycloaddition. Chem. Rev., 108, 2952-3015;
62. Rostovtsev, V.V., Green, L.G., Fokin, V.V., Sharpless, K.B. (2002). A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes, Angew. Chem. Int. Ed., 41, 2596-2599
63. Wu, P., Feldman, A.K., Nugent, A. K., Hawker, C.J., Scheel, A., Viot, B., Pyun, J., Frećhet, J.M. J., Sharpless, K.B., Fokin, V.V. (2004). Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(I)-catalyzed ligation of azides and alkynes. Angew. Chem. Int. Ed., 43, 3928-3932;
64. Himo, F., Lovell, T., Hilgraf, R., Rostovtsev, V.V., Noodleman, L., Sharpless, K.B., Fokin, V.V. (2005). Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. J. Am. Chem. Soc., 127, 210-216.
65. Touaibia, M.,Wellens, A., Shiao, T.C.,Wang, Q., Sirois, S., Bouckaert, J., Roy, R. (2007). Mannosylated G(0) dendrimers with nanomolar affinities to Escherichia coli FimH. ChemMedChem, 2, 1190-1201.
66. Gouin, S.G.,Wellens, A., Bouckaert, J., Kovensky, J. (2009). Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli. ChemMedChem, 4, 749-755.
67. Wellens, A., Garofalo, C., Nguyen, H., Van Gerven, N., Slättegård, R., Hernalsteens, J.-P., Wyns, L., Oscarson, S., De Greve, H., Hultgren, S., Bouckaert, J. (2008). Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimHoligomannose-3 complex. PLoS ONE, 3, e2040.
68. Merritt E.A., Hol, W.G.J. (1995). AB5 toxins. Curr. Opin. Struct. Biol., 5, 165-171.
69. Kitov, P.I., Sadowska, J.M., Mulvey, G., Armstrong, G.D., Ling, H., Pannu, N.S., Read, R.J., Bundle, D.R. (2000). Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature, 403, 669-672.
70. Mulvey, G.L., Marcato, P., Kitov, P.I., Sadowska, J., Bundle, D.R., Armstrong, G.D. (2003). Assessment in mice of the therapeutic potential of tailored, multivalent Shiga Toxin carbohydrate ligands. J. Infect. Dis., 187, 640-649.
71. Matsuoka, K., Terabatake, M., Esumi, Y., Terunuma, D., Kuzuhara, H. (1999). Synthetic assembly of trisaccharide moieties of globotriaosyl ceramide using carbosilane dendrimers as cores. A new type of functional glyco-material. Tetrahedron Lett., 40, 7839-7842.
72. Nishikawa, K., Matsuoka, K., Kita, E., Okabe, N., Mizugushi, M., Hino, K., Miyazawa, S., Yamasaki, C., Aoki, J., Takashima, S., Yamakawa, Y., Nishijima, M., Terunuma, D., Kuzuhara, H., Natori, Y. (2002). A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc. Natl. Acad. Sci., U.S.A. 99, 7669-7674.
73. Nishikawa, K., Matsuoka, K., Watanabe, M., Igai, K., Hino, K., Hatano, K., Yamada, A., Abe, N., Terunuma, D., Kuzuhara, H., Natori, Y. (2005). Identification of the optimal structure required for a Shiga Toxin neutralizer with oriented carbohydrates to function in the circulation. J. Infect. Dis., 191, 2097-2106.
74. Yamada, A., Hatano, K., Matsuoka, K., Koyama, T., Esumi, Y., Koshino, H., Hino, K., Nishikawa, K., Natori, Y., Terunuma, D. (2006). Syntheses and Vero toxin-binding activities of carbosilane. Tetrahedron, 62, 5074-5083.
75. Kale, R.R., McGannon, C.M., Fuller-Schaefer, C., Hatch, D.M., Flager, M.J., Gamage, S.D., Weiss, A.A., Iyer, S.S. (2008). Differentiation between structurally homologous Shiga 1 and Shiga 2 Toxins by using synthetic glycoconjugates. Angew. Chem. Int. Ed., 47, 1265-1268.
76. Vanden Broeck, D., Horvath, C., De Wolf, M.J.S. (2007). Vibrio cholera: cholera Toxin. Int. J. Biochem. Cell Biol., 39, 1771-1775.
77. Merritt, E.A., Sarfaty, S., Van Den Akker, F., L'Hoir, C., Martial, J.A., Hol, W.G.J. (1994). Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Prot. Sci., 3, 166-175;
78. Merritt, E.A., Kuhn, P., Sarfaty, S., Erbe, J.L., Holmes, R.K., Hol, W.G.J. (1998). The 1.25 Åresolution refinement of the cholera toxin B-pentamer: evidence of peptide backbone strain at the receptor-binding site. J. Mol. Biol., 282, 1043-1059.
79. Velter, I.A., Politi, M., Podlipnik, C., Nicotra, F. (2007). Natural and synthetic cholera toxin antagonists. Mini Rev. Med. Chem., 7, 159-170
80. Zhang, G. (2008). Design, synthesis, and evaluation of bisubstrate analog inhibitors of cholera toxin. Bioorg. Med. Chem. Lett., 18, 3724-3727.
81. Schengrund, C.-L., Ringler, N.J. (1989). Binding of Vibrio cholera toxin and the heatlabile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands. J. Biol. Chem., 264, 13233-13237.
82. Thompson, J.P., Schengrund, C.-L. (1997). Oligosaccharide-derivatized dendrimers: Defined multivalent inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1. Glycoconjugate J., 14, 837-845.
83. Arosio, D., Vrasidas, I., Valentini, P., Liskamp, R.M.J., Pieters, R.J., Bernardi, A. (2004). Synthesis and cholera toxin binding properties of multivalent GM1 mimics. Org. Biomol. Chem., 2, 2113-2124.
84. Pukin, A.V., Branderhorst, H.M., Sisu, C.,Weijers, C.A.G.M., Gilbert, M., Liskamp, R.M. J., Visser, G.M., Zuilhof, H., Pieters, R.J. (2007). Strong inhibition of cholera toxin by multivalent GM1 derivatives. ChemBioChem, 8, 1500-1503.
85. Bernardi, A. Carrettoni, L., Grosso Ciponte, A., Montib, D., Sonnino, S. (2000). Second generation mimics of ganglioside GM1 as artificial receptors for cholera toxin: replacement of the sialic acid moiety. Bioorg. Med. Chem. Lett., 10, 2197-2200.
86. Sisu, C., Baron, A.J., Branderhorst, H.M., Connell, S.D.,Weijers, C.A.G.M., de Vries, R., Hayes, E.D., Pukin, A.V., Gilbert, M., Pieters, R.J., Zuilhof, H., Visser, G.M., Turnbull, W.B. (2009). The influence of ligand valency on aggregation mechanisms for inhibiting bacterial toxins. ChemBioChem, 10, 329-337.
87. Dondoni, A., Marra, A. (2010). Calixarene and calixresorcarene glycosides: Their synthesis and biological applications. Chem. Rev., 110, 4949-4977.
88. Arosio, D., Fontanella, M., Baldini, L., Mauri, L., Bernardi, A., Casnati, A., Sansone, F., Ungaro, R. (2005). A synthetic divalent cholera toxin glycocalix[4]arene ligand having higher affinity than natural GM1 oligosaccharide. J. Am. Chem. Soc., 127, 3660-3661.
89. Branderhorst, H.M., Liskamp, R.M.J., Visser, G.M., Pieters, R.J. (2007). Strong inhibition of cholera toxin binding by galactose dendrimers. Chem. Commun., 5043-5045.
90. Vrasidas, I., de Mol, N.J., Liskamp, R.M.J., Pieters, R.J. (2001). Synthesis of lactose dendrimers and multivalency effects in binding to the cholera toxin B subunit. Eur. J. Org. Chem. 4685-4692.
91. Fan, E., Zhang, Z., Minke, W.E., Hou, Z., Verlinde, C.L.M.J., Hol, W.G.J. (2000). Highaffinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design. J. Am. Chem. Soc., 122, 2663-2664.
92. Meritt, E.A.,Zhang, Z., Pickens, J.C., Ahn, M.,Hol,W.G.J., Fan, E. (2002).Characterization and crystal structure of a high-affinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat-labile enterotoxin. J. Am. Chem. Soc., 124, 8818-8824.
93. Zhang, Z., Pickens, J.C., Hol,W.G.J., Fan, E. (2004). Solution-and solid-phase syntheses of guanidine-bridged, water-soluble linkers for multivalent ligand design. Org. Lett., 6, 1377-1380.
94. Zhang, Z., Merritt, E.A., Ahn, M., Roach, C., Hou, Z., Verlinde, C.L.M.J., Hol, W.G.J., Fan, E. (2002). Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin, J. Am. Chem. Soc., 124, 12991-12998.
95. Pickens, J.C., Mitchell, D.D., Liu, J., Tan, X., Zhang, Z., Verlinde, C.L.M.J., Hol,W.G.J., Fan, E. (2004). Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer. Chem. Biol., 11, 1205-1215.
96. Zhang, Z., Liu, J.,Verlinde, C.L.M.J., Hol,W.G.J., Fan, E. (2004). Large cyclic peptides as cores of multivalent ligands: application to inhibitors of receptor binding by cholera toxin. J. Org. Chem., 69, 7737-7740.
97. The Sugar Code (2009). Fundamentals of Glycosciences; Gabius, H.-J. Ed., Wiley-VCH Verlag Gmbh & Co, Weinheim.
98. Roy, R., Shiao, T.C. (2011). Organic chemistry and immunochemical strategies in the design of potent carbohydrate-based vaccines. Chimia, 65, 24-29.
99. Grandjean, C., Angyalosi, G., Loing, E., Adriaenssens, E., Melnyk, O., Pancré, V., Auriault, C., Gras-Masse, H. (2001). Novel hyperbranched glycomimetics recognized by the human mannose receptor: quinic and Shikimic derivatives as mannose bioisosteres. ChemBioChem, 2, 747-757.
100. Dubber, M., Frećhet, J.M.J. (2003). Solid-phase synthesis of multivalent glycoconjugates on a DNA synthesizer. Bioconjugate Chem., 14, 239-246.
101. Zheng, X., Pandey, R.K. (2008). Porphyrin-carbohydrate conjugates: impact of carbohydrate moieties in photodynamic therapy (PDT). Anti-Cancer in Med. Chem., 8, 241-268.